- Home
- CTSO vs STEC Comparison
CTSO vs STEC Comparison
Compare CTSO & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- STEC
- Stock Information
- Founded
- CTSO 1997
- STEC 2006
- Country
- CTSO United States
- STEC Hong Kong
- Employees
- CTSO N/A
- STEC N/A
- Industry
- CTSO Medical/Dental Instruments
- STEC
- Sector
- CTSO Health Care
- STEC
- Exchange
- CTSO Nasdaq
- STEC NYSE
- Market Cap
- CTSO 65.7M
- STEC 63.8M
- IPO Year
- CTSO N/A
- STEC 2021
- Fundamental
- Price
- CTSO $0.95
- STEC $0.74
- Analyst Decision
- CTSO Buy
- STEC
- Analyst Count
- CTSO 2
- STEC 0
- Target Price
- CTSO $5.50
- STEC N/A
- AVG Volume (30 Days)
- CTSO 93.3K
- STEC 10.9K
- Earning Date
- CTSO 08-07-2025
- STEC 08-05-2025
- Dividend Yield
- CTSO N/A
- STEC N/A
- EPS Growth
- CTSO N/A
- STEC N/A
- EPS
- CTSO N/A
- STEC N/A
- Revenue
- CTSO $35,332,238.00
- STEC $10,672,000.00
- Revenue This Year
- CTSO $11.15
- STEC $9,392.20
- Revenue Next Year
- CTSO $21.39
- STEC N/A
- P/E Ratio
- CTSO N/A
- STEC N/A
- Revenue Growth
- CTSO 15.37
- STEC N/A
- 52 Week Low
- CTSO $0.71
- STEC $0.20
- 52 Week High
- CTSO $1.61
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- CTSO 39.94
- STEC 37.66
- Support Level
- CTSO $0.91
- STEC $0.69
- Resistance Level
- CTSO $1.06
- STEC $0.80
- Average True Range (ATR)
- CTSO 0.06
- STEC 0.08
- MACD
- CTSO -0.01
- STEC 0.00
- Stochastic Oscillator
- CTSO 13.97
- STEC 30.49
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.